Henry Shelton Earp

11PUBLICATIONS
67CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|Feb 12, 2025
PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy.

Nestor Prieto-Dominguez, Paran Goel, Oluwagbemiga A Ojo

|Sep 06, 2024
The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research.

Chelsea Anderson, Jeannette T Bensen, Emma H Allott

|Aug 29, 2024
MERTK Is a Potential Therapeutic Target in Ewing Sarcoma.

Sherri K Smart, Tsz Y Yeung, M Olivia Santos

|Jul 27, 2024
MERTK Inhibition as a Targeted Novel Cancer Therapy.

K M Tanim, Alisha Holtzhausen, Aashis Thapa

|Jul 16, 2024
Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer.

Sarah C Van Alsten, Sanah N Vohra, Joannie M Ivory

Pageof 2

Frequent Collaborators

3 joint publications

Alisha Holtzhausen

3 joint publications

Charles M Perou

2 joint publications

Stephen V Frye

2 joint publications

Lisa A Carey